Activated α2macroglobulin increases β-amyloid (25-35)-induced toxicity in LAN5 human neuroblastoma cells

Experimental Neurology

Volumn 155, Issue 2, 1999, Pages 252-259

  Fabrizi, C ^a   Businaro, R ^b   Lauro, G M ^a   Starace, G ^c   Fumagalli, L ^b  

^a ROMA TRE UNIVERSITY   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c CNR   (Italy)

Author keywords

Alzheimer's disease; Amyloid; Neurotoxicity; Protease inhibitors; TGF ; 2macroglobulin; 2macroglobulin receptor

Indexed keywords

ALPHA 2 MACROGLOBULIN; AMYLOID; AMYLOID BETA PROTEIN; CYTOKINE; HORMONE; INSULIN; NERVE GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; AMYLOID BETA PROTEIN (25 35); AMYLOID BETA-PROTEIN (25-35); BLOCKING ANTIBODY; PEPTIDE FRAGMENT;

ALZHEIMER DISEASE; ARTICLE; CELL COUNT; CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NERVE DEGENERATION; NEUROBLASTOMA CELL; NEUROPROTECTION; NEUROTOXICITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SENILE PLAQUE; BRAIN TUMOR; CELL SURVIVAL; DRUG ANTAGONISM; DRUG EFFECT; IMMUNOLOGY; METABOLISM; NEUROBLASTOMA; PATHOLOGY; PHYSIOLOGY;

ALPHA-MACROGLOBULINS; AMYLOID BETA-PROTEIN; ANTIBODIES, BLOCKING; BRAIN NEOPLASMS; CELL SURVIVAL; FLOW CYTOMETRY; HUMANS; NEUROBLASTOMA; PEPTIDE FRAGMENTS; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0032587596     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1998.6978     Document Type: Article

References (49)

1. 1. Cell. 52:1988;487-501.
2. 1. Neurosci. Lett. 217:1996;117-120.
3. Barger S. W., Harmon A. D. Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature. 388:1997;878-881.
4. 2. Methods Enzymol. 80:1981;737-754.
5. 2. FEBS Lett. 285:1991;111-114.
6. 2. Biochem J. 207:1982;347-356.
7. 2. Exp. Brain Res. 88:1992;213-218.
8. 2. J. Neuroimmunol. 72:1997;75-81.
9. Cataldo A. M., Barnett J. L., Mann D. M., Nixon R. A. Colocalization of lysosomal hydrolase and β-amyloid in diffuse plaques of the cerebellum and striatum in Alzheimer's disease and Down's syndrome. J. Neuropathol. Exp. Neurol. 55:1996;704-715.
10. Cone J. L., Brown D. R., De Larco J. E. An improved method for purification of transforming growth factor, type beta, from platelets. Anal. Biochem. 168:1988;71-74.
11. 2. J. Biol. Chem. 269:1994;1533-1540.
12. 122. J. Biol. Chem. 265:1990;6973-6977.
13. Dickson D. W. The pathogenesis of senile plaques. Neuropathol. Exp. Neurol. 56:1997;321-339.
14. 2. J. Neurochem. 70:1998;1182-1188.
15. Eikelenboom P., Stam F. C. Immunoglobulins and complement factors in senile plaques. An immunoperoxidase study. Acta Neuropathol. (Berl.). 57:1982;239-242.
16. 2. J. Neuroimmunol. 53:1994;31-37.
17. Feige J. J., Negoescu A., Keramidas M., Souchelnitskiy S., Chambaz E. M. Macroglobulin: A binding protein for Transforming Growth Factor-β and various cytokines. Horm. Res. 45:1996;227-232.
18. Gitter B. D., Cox L. M., Rydel R. E., May P. C. Amyloid peptide potentiates cytokine secretion by interleukin-1β-activated human astrocytoma cells. Proc. Natl. Acad. Sci. USA. 92:1995;10738-10741.
19. Goodman Y., Mattson M. P. Secreted forms of β-amyloid precursor protein protect hippocampal neurons against amyloid β-peptide-induced oxidative injury. Exp. Neurol. 128:1994;1-12.
20. Hansen M. B., Nielsen S. E., Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Meth. 119:1989;203-210.
21. Ii K., Ito H., Kominami E., Irano A. Abnormal distribution of cathepsin proteinases and endogenous inhibitors (cystatins) in the hippocampus of patients with Alzheimer's disease. Virchows. Arch. A Pathol. Anat. Histopathol. 423:1993;185-194.
22. Kawamata T., Tooyama I., Yamada T., Walker D. G., McGeer P. L. Lactotransferrin immunocytochemistry in Alzheimer and normal human brain. Am. J. Pathol. 142:1993;1574-1585.
23. 1. Endocrinology. 129:1991;517-526.
24. Kosik K. S. Alzheimer's disease: A cell biological perspective. Science. 256:1992;780-783.
25. Kounnas M. Z., Moir R. D., Rebeck G. W., Bush A. I., Argraves W. S., Tanzi R. E., Hyman B. T., Strickland D. K. LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted β-amyloid precursor protein and mediates its degradation. Cell. 82:1995;331-340.
26. Lampariello F. Evaluation of the number of positive cells from flow cytometric immunoassays by mathematical modeling of cellular autofluorescence. Cytometry. 15:1994;294-301.
27. 2. J. Biol. Chem. 270:1995;21919-21927.
28. Mattson M. P., Barger S. W., Furukawa K., Bruce A. J., Wyss-Coray T., Mark R. J., Mucke L. Cellular signaling roles of TGFβ, TNFα and βApp in brain injury responses and Alzheimer's disease. Brain Res. Rev. 23:1997;47-61.
29. 2. Leukem. Res. 16:1992;227-234.
30. 2. Biochim. Biophys. Acta. 197:1994;197-213.
31. Mrak R. E., Sheng J. C., Griffin W. S. Glial cytokines in Alzheimer's disease: Review and pathogenic implications. Hum. Pathol. 26:1995;816-823.
32. 2. J. Biol. Chem. 262:1987;14090-14099.
33. Prehn J. H. M., Backhauss L., Krieglstein J. Transforming growth factor-β prevents glutamate neurotoxicity in rat neocortical cultures and protect mouse neocortex from ischemic injuryin vivo. J. Cerebral Blood Flow Metab. 13:1993;521-525.
34. 1. Mol. Pharmacol. 49:1996;319-328.
35. 2. J. Biol. Chem. 271:1996;8443-8451.
36. Rebeck G. W., Reiter J. S., Strickland D. K., Hyman B. T. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron. 11:1993;575-580.
37. Ren R. F., Flanders K. C. Transforming growth factors-β protect primary rat hippocampal neuronal cultures from degeneration induced by β-amyloid peptide. Brain Res. 732:1996;16-24.
38. Scarpa S., Coppa A., Ragano-Caracciolo M., Mincione G., Giuffrida A., Modesti A., Colletta G. Transforming growth factor-β regulates differentiation and proliferation of human neuroblastoma. Exp. Cell Res. 229:1996;147-154.
39. Selkoe D. J. Physiological production of the β-amyloid protein and the mechanism of Alzheimer's disease. Trends Neurosci. 16:1993;403-409.
40. 1. Biochem. Biophys. Res. Commun. 193:1993;579-584.
41. Starkey P. M., Barrett A. J., Burleigh M. C. The degradation of articular collagen by neutrophil proteinases. Biochim. Biophys. Acta. 483:1977;386-397.
42. 2. Lab. Invest. 66:1992;223-230.
43. 22. Brain Res. 777:1997;223-227.
44. Unsicker K., Flanders K. C., Cissel D. S., Lafyatis R., Sporn M. B. Transforming growth factorβ isoforms in the adult rat central and peripheral nervous system. Neuroscience. 44:1991;613-625.
45. 1. NeuroReport. 4:1993;69-72.
46. 2. Neurobiol. Aging. 14:1993;233-237.
47. 2. FEBS. 410:1997;249-253.
48. Willis G. L. Amine accumulation in Parkinson's disease and other disorders. Neurosci. Biobehav. Rev. 11:1987;97-105.
49. 2. Biochemistry. 33:1994;11270-11277.